None listed
Conditions
Interventions
Others : Panic Disorder-Experimental Group (n=28): Participants will be provided with a digital Cognitive Behavioral Therapy (dCBT) application focused on Interoceptive Exposure Therapy. All participa
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: To be eligible for the study, individuals must meet all of the following criteria: 1) Are diagnosed with panic disorder or a panic attack specifier by a psychiatrist according to DSM-5 criteria. 2) Score 7 or above on the Korean version of the Panic Disorder Severity Scale. 3) Are able to understand and participate in cognitive behavioral therapy. 4) Are able to use wearable devices and the application. 5) Have listened to the explanation of this study and have consented to participate.
Exclusion criteria
Exclusion criteria: Individuals will be excluded from the study if they meet any of the following criteria: 1) Are participating in another therapy program that prohibits concurrent participation in non-pharmacological treatment programs, or have received cognitive behavioral therapy for panic disorder within the past three months. 2) Have accompanying internal medicine or neurological disorders. 3) Exhibit current psychotic symptoms. 4) Are diagnosed with schizophrenia, schizoaffective disorder, cognitive disorders, or impulse control disorders. 5) Are assessed to have a high risk of suicide during a clinical interview.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Panic Disorder Severity Scale (PDSS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Interoceptive fear/avoidance subfactor score of the PDSS;Albany Panic and Phobia Questionnaire (APPQ);Panic Disorder Severity Scale - Self rating (PDSS-SR);Anxiety Severity Index-Revised (ASI-R);Beck Anxiety Inventory (BAI);Beck Depression Inventory (BDI);Subjective Units of Disturbance scales (SUDs);Heart Rate;Heart Rate Variability;Skin conductance;Prothrombin Time (PT), activated partial thromboplastin time(aPTT), von Willebrand factor, Thrombin- AntiThrombin complex (TAT complex), Plasminogen activator inhibitor-1, plasminogen, fibrinogen, D-dimer, Coagulation Factor VII, contact activation system;Digital phenotype (Keytstroke dynamics, step , illuminance, GPS);Digital literacy;Usability evaluation of the app and wearable device;quantitative electroencephalograph (qEEG);Clinical Global Impression (CGI) | — |
Countries
Korea, Republic of
Contacts
Public ContactSoo-Jin Kwak
Seoul National University Hospital
Outcome results
None listed